VE-Cadherin is a well-known factor for increased vascular permeability in estrogen-positive breast cancer57 and its expression correlates with poor survival prognosis in human gastric cancer and can therefore be used as a biomarker58,59. Here, CDH5 is linked to gastric cancer.